BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6274453)

  • 21. Fibrin protofibril and fibrinogen binding to ADP-stimulated platelets: evidence for a common mechanism.
    Hantgan RR
    Biochim Biophys Acta; 1988 Jan; 968(1):24-35. PubMed ID: 2827786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane.
    DiMinno G; Silver MJ; Cerbone AM; Riccardi G; Rivellese A; Mancini M; Thiagarajan P
    Blood; 1985 Jan; 65(1):156-62. PubMed ID: 2981130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognition of platelet-associated fibrinogen by polyclonal antibodies: correlation with platelet aggregation.
    Peerschke EI
    Blood; 1992 Apr; 79(8):2028-33. PubMed ID: 1562729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinogen interaction with platelet receptors.
    Niewiarowski S; Kornecki E; Budzynski AZ; Morinelli TA; Tuszynski GP
    Ann N Y Acad Sci; 1983 Jun; 408():536-55. PubMed ID: 6307105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exposure of platelet fibrinogen receptors by zinc ions: role of protein kinase C.
    Trybulec M; Kowalska MA; McLane MA; Silver L; Lu W; Niewiarowski S
    Proc Soc Exp Biol Med; 1993 May; 203(1):108-16. PubMed ID: 8475131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased binding to ADP-stimulated platelets and aggregation effect of the dysfibrinogen Oslo I as compared with normal fibrinogen.
    Thorsen LI; Brosstad F; Solum NO; Stormorken H
    Scand J Haematol; 1986 Feb; 36(2):203-10. PubMed ID: 3010440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Participation of ADP in the binding of fibrinogen to thrombin-stimulated platelets.
    Plow EF; Marguerie GA
    Blood; 1980 Sep; 56(3):553-5. PubMed ID: 7407418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exposure of platelet fibrinogen receptors by ADP and epinephrine.
    Bennett JS; Vilaire G
    J Clin Invest; 1979 Nov; 64(5):1393-401. PubMed ID: 574143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists.
    Shattil SJ; Budzynski A; Scrutton MC
    Blood; 1989 Jan; 73(1):150-8. PubMed ID: 2535942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex.
    Di Minno G; Thiagarajan P; Perussia B; Martinez J; Shapiro S; Trinchieri G; Murphy S
    Blood; 1983 Jan; 61(1):140-8. PubMed ID: 6216929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder.
    Hardisty R; Pidard D; Cox A; Nokes T; Legrand C; Bouillot C; Pannocchia A; Heilmann E; Hourdillé P; Bellucci S
    Blood; 1992 Aug; 80(3):696-708. PubMed ID: 1638023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The fibrinogen-dependent pathway of platelet aggregation.
    Marguerie GA; Plow EF
    Ann N Y Acad Sci; 1983 Jun; 408():556-66. PubMed ID: 6307106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering.
    Isenberg WM; McEver RP; Phillips DR; Shuman MA; Bainton DF
    J Cell Biol; 1987 Jun; 104(6):1655-63. PubMed ID: 3584243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
    Peerschke EI
    Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen binding to human blood platelets: effect of gamma chain carboxyterminal structure and length.
    Peerschke EI; Francis CW; Marder VJ
    Blood; 1986 Feb; 67(2):385-90. PubMed ID: 3942829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of heterologous fibrinogens with human platelet receptors.
    Nowak P; Krajewski T; Pietrucha T; Cierniewski C
    Acta Biochim Pol; 1991; 38(1):91-4. PubMed ID: 1665672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypersensitivity to ADP of platelets from diabetic rats associated with enhanced fibrinogen binding.
    Winocour PD; Perry DW; Kinlough-Rathbone RL
    Eur J Clin Invest; 1992 Jan; 22(1):19-23. PubMed ID: 1559539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic measurements of the platelet membrane glycoprotein IIb-IIIa receptor for fibrinogen by flow cytometry. II. Platelet size-dependent subpopulations.
    Frojmovic M; Wong T
    Biophys J; 1991 Apr; 59(4):828-37. PubMed ID: 1905967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of fibrinogen receptor expression on platelets activated in normal plasma with ADP: analysis by flow cytometry.
    Jackson CW; Jennings LK
    Br J Haematol; 1989 Jul; 72(3):407-14. PubMed ID: 2765407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.
    Lombardo VT; Hodson E; Roberts JR; Kunicki TJ; Zimmerman TS; Ruggeri ZM
    J Clin Invest; 1985 Nov; 76(5):1950-8. PubMed ID: 2414325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.